Liver transplantation: an update 2007
暂无分享,去创建一个
[1] M. Abecassis,et al. Improvement in survival associated with adult-to-adult living donor liver transplantation. , 2007, Gastroenterology.
[2] R. Wiesner,et al. Differential Effects of Donor Age in Liver Transplant Recipients Infected With Hepatitis B, Hepatitis C and Without Viral Hepatitis , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[3] H. Nivet,et al. Early Pulse Pressure and Low‐Grade Proteinuria as Independent Long‐Term Risk Factors for New‐Onset Diabetes Mellitus After Kidney Transplantation , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[4] P. Nyckowski,et al. Renal function after liver transplantation: calcineurin inhibitor nephrotoxicity. , 2003, Transplantation proceedings.
[5] R. Weber,et al. Are HIV-infected patients candidates for liver transplantation? , 2008, Journal of hepatology.
[6] Zhao-You Tang,et al. Effect of Rapamycin Alone and in Combination with Sorafenib in an Orthotopic Model of Human Hepatocellular Carcinoma , 2008, Clinical Cancer Research.
[7] H. Feucht. Significance of donor-specific antibodies in acute rejection. , 2005, Transplantation proceedings.
[8] M. Orloff,et al. Characterization of CD4, CD8, CD56 positive lymphocytes and C4d deposits to distinguish acute cellular rejection from recurrent hepatitis C in post‐liver transplant biopsies , 2006, Clinical transplantation.
[9] J. Bruix,et al. Intention‐to‐treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation , 1999, Hepatology.
[10] M. Stegall,et al. Chronic renal dysfunction late after liver transplantation , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[11] J. Roberts,et al. Liver Transplantation for Hepatocellular Carcinoma: Validation of the UCSF‐Expanded Criteria Based on Preoperative Imaging , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[12] I. Bilbao,et al. Liver transplantation in HIV-HCV coinfected patients: a case-control study. , 2007, Transplantation.
[13] D. Douglas,et al. Natural history of hepatitis C following liver transplantation , 2004, Current opinion in infectious diseases.
[14] D. Nelson,et al. Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[15] M. Berenguer. What determines the natural history of recurrent hepatitis C after liver transplantation? , 2005, Journal of hepatology.
[16] D. Fine,et al. Independent risk factors and natural history of renal dysfunction in liver transplant recipients , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[17] B. Spiegel,et al. A comparison of liver transplantation outcomes in the pre‐ vs. post‐MELD eras , 2005, Alimentary pharmacology & therapeutics.
[18] N. Terrault. Treatment of recurrent hepatitis C in liver transplant recipients. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[19] J. Palefsky,et al. Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study1 , 2003, Transplantation.
[20] Mohamed Rela,et al. Pretransplant MELD score and post liver transplantation survival in the UK and Ireland , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[21] U. Neumann,et al. Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: A single‐center study of 289 patients , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[22] M. Falster,et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis , 2007, The Lancet.
[23] U. Neumann,et al. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up , 2004, Transplantation.
[24] A. Lok,et al. Outcomes in hepatitis C virus–infected recipients of living donor vs. deceased donor liver transplantation , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[25] J. Barkun,et al. Evaluation of renal function in liver transplant recipients receiving daclizumab (Zenapax), mycophenolate mofetil, and a delayed, low‐dose tacrolimus regimen vs. a standard‐dose tacrolimus and mycophenolate mofetil regimen: A multicenter randomized clinical trial , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[26] M. Haberal,et al. Right hepatic lobe donation: impact on donor quality of life. , 2007, Transplantation proceedings.
[27] R. Fisher,et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death , 2004, Hepatology.
[28] R. Striker,et al. EFFECT OF ANTIMETABOLITE IMMUNOSUPPRESSANTS ON FLAVIVIRIDAE, INCLUDING HEPATITIS C VIRUS , 2004, Transplantation.
[29] J. Torre-Cisneros,et al. Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease , 2006, AIDS.
[30] D. Seehofer,et al. Long‐term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[31] A. Dhillon,et al. Liver transplantation for HCV cirrhosis: Improved survival in recent years and increased severity of recurrent disease in female recipients: Results of a long term retrospective study , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[32] P. Kamath,et al. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts , 2000, Hepatology.
[33] T. Pfammatter,et al. Transarterial Chemoembolization as a Bridge to Liver Transplantation for Hepatocellular Carcinoma: An Evidence‐Based Analysis , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[34] G. Loss,et al. Sirolimus monotherapy in nephrotoxicity due to calcineurin inhibitors in liver transplant recipients , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[35] J. Roberts,et al. Experience with daclizumab in liver transplantation: renal transplant dosing without calcineurin inhibitors is insufficient to prevent acute rejection in liver transplantation. , 2000, Transplantation.
[36] G. Klintmalm,et al. A Comparison of Tacrolimus and Cyclosporine in Liver Transplantation: Effects on Renal Function and Cardiovascular Risk Status , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[37] S. Roayaie,et al. Treatment of HCC in Patients Awaiting Liver Transplantation , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[38] V. Mazzaferro,et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.
[39] E. Schiff,et al. Outcomes After Orthotopic Liver Transplantation in 15 HIV-Infected Patients , 2007, Transplantation.
[40] ndrea,et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. , 1996, The New England journal of medicine.
[41] K. Reddy,et al. Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation. , 1998, Transplantation.
[42] A. Demetris,et al. Survival of Liver Transplant Patients Coinfected with HIV and HCV Is Adversely Impacted by Recurrent Hepatitis C , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[43] R. Fisher,et al. Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[44] Nick Murphy,et al. Self-Organizing Maps Can Determine Outcome and Match Recipients and Donors at Orthotopic Liver Transplantation , 2005, Transplantation.
[45] C. Kin,et al. Extended-donor criteria liver allografts. , 2006, Seminars in liver disease.
[46] I. Horwitz,et al. Waitlist Mortality Decreases with Increased Use of Extended Criteria Donor Liver Grafts at Adult Liver Transplant Centers , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[47] Sammy Saab,et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation , 2005, Hepatology.
[48] J. Carter,et al. Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[49] P. Neuhaus,et al. Living donor liver transplantation of the right lobe for hepatocellular carcinoma in cirrhosis in a European center , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[50] G. Gerken,et al. Impact of combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy on renal function, cardiovascular risk factors, and graft function in liver transplant patients: preliminary results of an open prospective study. , 2004, Transplantation proceedings.
[51] M. G. Krukemeyer,et al. C4d in Acute Rejection After Liver Transplantation—A Valuable Tool in Differential Diagnosis to Hepatitis C Recurrence , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[52] G. Testa,et al. Right‐liver living donor transplantation for decompensated end‐stage liver disease , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[53] J. Saric,et al. Renal failure after liver transplantation: outcome after calcineurin inhibitor withdrawal , 2002, Clinical transplantation.
[54] R. Striker,et al. Sensitivity of hepatitis C virus to cyclosporine A depends on nonstructural proteins NS5A and NS5B , 2007, Hepatology.
[55] J. Albrecht,et al. Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study. , 2003, Gastroenterology.
[56] L. Ferrell,et al. HCV-related fibrosis progression following liver transplantation: increase in recent years. , 2000, Journal of hepatology.
[57] M. Navasa,et al. Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation. , 2006, Gastroenterology.
[58] D. Streblow,et al. Cyclophilin a modulates processing of human immunodeficiency virus type 1 p55Gag: mechanism for antiviral effects of cyclosporin A. , 1998, Virology.
[59] D. Auclair,et al. BAY 43-9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis , 2004, Cancer Research.
[60] T. Davern,et al. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[61] M. De Luca,et al. Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation. , 2007, Journal of hepatology.
[62] R. Gish,et al. A model to predict severe HCV‐related disease following liver transplantation , 2003, Hepatology.
[63] M. Peters,et al. HIV and liver disease forum: Conference proceedings , 2007, Hepatology.
[64] J. Trotter,et al. Expanding donor options: marginal, living, and split donors. , 2007, Clinics in liver disease.
[65] W. Jaschke,et al. Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[66] I. McGilvray,et al. Reduced Mortality with Right‐Lobe Living Donor Compared to Deceased‐Donor Liver Transplantation When Analyzed from the Time of Listing , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[67] C. Sabin,et al. Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[68] D. Theriaque,et al. One‐year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[69] J. Prieto,et al. Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil. , 1999, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[70] H. Yoo,et al. Short‐term postliver transplant survival after the introduction of MELD scores for organ allocation in the United States , 2005, Liver international : official journal of the International Association for the Study of the Liver.
[71] S. Biggins,et al. Retransplantation for hepatitis C: Results of a U.S. multicenter retransplant study , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[72] A. Mclellan,et al. Interpreting the significance of drinking by alcohol‐dependent liver transplant patients: Fostering candor is the key to recovery , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[73] X. Forns,et al. Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study. , 2007, Gastroenterology.
[74] R. Wiesner,et al. Predictors of patient and graft survival following liver transplantation for hepatitis C , 1998, Hepatology.
[75] C. Trépo,et al. Histological Benefit of Retreatment by Pegylated Interferon Alfa‐2b and Ribavirin in Patients with Recurrent Hepatitis C Virus Infection Posttransplantation , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[76] T. Gonwa,et al. Continued Influence of Preoperative Renal Function on Outcome of Orthotopic Liver Transplant (OLTX) in the US: Where Will MELD Lead Us? , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[77] A. Burroughs,et al. Long-term mycophenolate mofetil monotherapy in combination with calcineurin inhibitors for chronic renal dysfunction after liver transplantation , 2003, Transplantation.
[78] R. Wiesner,et al. Results of the first year of the new liver allocation plan , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[79] U. Neumann,et al. Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss. , 2005, Transplantation proceedings.
[80] N. Terrault,et al. A pilot study of the tolerability and efficacy of antiviral therapy in hepatitis C virus–infected patients awaiting liver transplantation , 2002, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[81] W. Chapman,et al. Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. , 2006, Journal of the American College of Surgeons.
[82] B. Gillespie,et al. Severe Psychiatric Problems in Right Hepatic Lobe Donors for Living Donor Liver Transplantation , 2007, Transplantation.
[83] A. Lok,et al. Recipient Morbidity After Living and Deceased Donor Liver Transplantation: Findings from the A2ALL Retrospective Cohort Study† , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[84] J. Everhart,et al. Outcomes of donor evaluation in adult‐to‐adult living donor liver transplantation , 2007, Hepatology.
[85] L. Magder,et al. Impact of Human Immunodeficiency Virus on Survival After Liver Transplantation: Analysis of United Network for Organ Sharing Database , 2008, Transplantation.
[86] M. Dew,et al. Alcohol consumption patterns and predictors of use following liver transplantation for alcoholic liver disease , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[87] M. Hudson,et al. Mycophenolate mofetil monotherapy in liver transplantation , 2001, The Lancet.
[88] K. Saeian,et al. MELD Score Does Not Discriminate Against Patients with Hepatic Encephalopathy , 2005, Digestive Diseases and Sciences.
[89] R. Wiesner,et al. Report of the First International Liver Transplantation Society Expert Panel Consensus Conference on Liver Transplantation and Hepatitis C , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[90] G. Otto,et al. Transarterial chemoembolization before liver transplantation in 60 patients with hepatocellular carcinoma. , 2007, Transplantation proceedings.
[91] J. Barkun,et al. EFFICACY OF MYCOPHENOLATE MOFETIL COMBINED WITH VERY LOW‐DOSE CYCLOSPORINE MICROEMULSION IN LONG‐TERM LIVER‐TRANSPLANT PATIENTS WITH RENAL DYSFUNCTION , 2003, Transplantation.
[92] E. Schiff,et al. Orthotopic liver transplantation in patients with human immunodeficiency virus and end‐stage liver disease , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[93] Ryutaro Hirose,et al. Excellent outcome following down‐staging of hepatocellular carcinoma prior to liver transplantation: An intention‐to‐treat analysis , 2008, Hepatology.
[94] J. Emond,et al. Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donors , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[95] R. Wolfe,et al. Chronic renal failure after transplantation of a nonrenal organ. , 2003, The New England journal of medicine.
[96] M. Choi,et al. Milan criteria are useful predictors for favorable outcomes in hepatocellular carcinoma patients undergoing liver transplantation after transarterial chemoembolization. , 2006, World journal of gastroenterology.
[97] J. Zamora,et al. Immunosuppression with calcineurin inhibitors with respect to the outcome of HCV recurrence after liver transplantation: Results of a meta‐analysis , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[98] Dieter Häussinger,et al. Sorafenib in advanced hepatocellular carcinoma. , 2008, The New England journal of medicine.
[99] K. Boudjema,et al. C4d: a marker for hepatic transplant rejection. , 2006, Transplantation proceedings.
[100] D. Samuel,et al. Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus , 2007, Hepatology.
[101] T. Powles,et al. Hepatocellular carcinoma, human immunodeficiency virus and viral hepatitis in the HAART era. , 2008, World journal of gastroenterology.
[102] N. Heaton,et al. Survival of human immunodeficiency virus-infected liver transplant recipients. , 2003, The Journal of infectious diseases.
[103] Mark J. Thomas,et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[104] V. Paradis,et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma before liver transplantation: a prospective study with histopathologic comparison. , 2006, AJR. American journal of roentgenology.
[105] G. Silberhumer,et al. Combination of Extended Donor Criteria and Changes in the Model for End-Stage Liver Disease Score Predict Patient Survival and Primary Dysfunction in Liver Transplantation: A Retrospective Analysis , 2007, Transplantation.
[106] G. Otto,et al. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[107] G. Klintmalm,et al. Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: A report from the International Registry of Hepatic Tumors in Liver Transplantation , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[108] P. Waldenberger,et al. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[109] A. Jain,et al. Living‐Donor Liver Transplantation in the United States: Identifying Donors at Risk for Perioperative Complications , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[110] D. Samuel,et al. Effect of Highly Active Antiretroviral Therapy on Tacrolimus Pharmacokinetics in Hepatitis C Virus and HIV Co-Infected Liver Transplant Recipients in the ANRS HC-08 Study , 2007, Clinical pharmacokinetics.
[111] T. Pruett,et al. Donor Factors Predicting Recipient Survival After Liver Retransplantation: The Retransplant Donor Risk Index , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[112] A. Lok,et al. Hepatocellular Carcinoma Recurrence and Death Following Living and Deceased Donor Liver Transplantation , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[113] P. Marik,et al. The course of type 1 hepato-renal syndrome post liver transplantation. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[114] P Neuhaus,et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis , 2001, Hepatology.
[115] A. Moya,et al. Contribution of donor age to the recent decrease in patient survival among HCV‐infected liver transplant recipients , 2002, Hepatology.
[116] E. Edwards,et al. Utilization of Extended Donor Criteria Liver Allograft: Is the Elevated Risk of Failure Independent of the Model for End-Stage Liver Disease Score of the Recipient? , 2006, Transplantation.
[117] C. von Kalle,et al. Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib® versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation – HeiLivCa [ISRCTN24081794] , 2008, BMC Cancer.
[118] M. Manns,et al. Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil. , 2000, Transplantation.
[119] G. Everson,et al. Treatment of advanced hepatitis C with a low accelerating dosage regimen of antiviral therapy , 2005, Hepatology.
[120] T. Therneau,et al. Evidence-based incorporation of serum sodium concentration into MELD. , 2006, Gastroenterology.
[121] J. Llovet,et al. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation , 2004, Hepatology.
[122] J. Bragg-Gresham,et al. Characteristics Associated with Liver Graft Failure: The Concept of a Donor Risk Index , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[123] K. Shimotohno,et al. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes , 2003, Hepatology.
[124] J. Scheele,et al. Introduction of MMF in conjunction with stepwise reduction of calcineurin inhibitor in stable liver transplant patients with renal dysfunction. , 2005, International immunopharmacology.
[125] U. Christians,et al. Cyclosporine Pharmacokinetics and Dosing Modifications in Human Immunodeficiency Virus-Infected Liver and Kidney Transplant Recipients , 2005, Transplantation.
[126] M. Katze,et al. Gene expression patterns that correlate with hepatitis C and early progression to fibrosis in liver transplant recipients. , 2006, Gastroenterology.
[127] K. Richardson,et al. Interferon‐Based Combination Anti‐Viral Therapy for Hepatitis C Virus After Liver Transplantation: A Review and Quantitative Analysis , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[128] A. Venook,et al. Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival , 2001, Hepatology.
[129] P. Angeli,et al. Intention‐to‐Treat Analysis of Liver Transplantation in Selected, Aggressively Treated HCC Patients Exceeding the Milan Criteria , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[130] C. Broelsch,et al. Psychological strain in urgent indications for living donor liver transplantation , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[131] S. Hossain,et al. Impact of donor age on survival and fibrosis progression in patients with hepatitis C undergoing liver transplantation using HCV+ allografts , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[132] I. Ng,et al. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma , 2007, The British journal of surgery.
[133] J. Dumortier,et al. Impact of adult‐to‐adult living donor liver transplantation on access to transplantation and patients' survival: An 8‐year single‐center experience , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[134] F. Roudot-thoraval,et al. Impact of UCSF criteria according to pre‐ and post‐OLT tumor features: Analysis of 479 patients listed for HCC with a short waiting time , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[135] L. Mariani,et al. Radiofrequency Ablation of Small Hepatocellular Carcinoma in Cirrhotic Patients Awaiting Liver Transplantation: A Prospective Study , 2004, Annals of surgery.
[136] G. Klintmalm,et al. Impact of tacrolimus versus cyclosporine in hepatitis C virus‐infected liver transplant recipients on recurrent hepatitis: A prospective, randomized trial , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[137] M. Mihatsch,et al. THE EFFECT OF CYCLOSPORINE ON THE PROGRESSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 INFECTION TRANSMITTED BY TRANSPLANTATION–DATA ON FOUR CASES AND REVIEW OF THE LITERATURE , 1993, Transplantation.
[138] M. Vogel,et al. Antiviral therapy for hepatitis C virus recurrence after liver transplantation in HIV-infected patients: outcome in the Bonn cohort , 2007, AIDS.
[139] Robert S Brown,et al. Live donors in liver transplantation. , 2008, Gastroenterology.
[140] Peter Bacchetti,et al. Serum sodium predicts mortality in patients listed for liver transplantation , 2005, Hepatology.
[141] R. Wiesner,et al. Model for end-stage liver disease (MELD) and allocation of donor livers. , 2003, Gastroenterology.
[142] J. Emond,et al. Donor morbidity after living donation for liver transplantation. , 2008, Gastroenterology.
[143] A. Tannapfel,et al. Impact of mycophenolate mofetil versus azathioprine on early recurrence of hepatitis C after liver transplantation. , 2005, International immunopharmacology.